“No molecule is too difficult when you have the R&D know-how.”
“Strong patent intelligence precedes outstanding success.”
IP Advantage | Patent Intelligence | Non-infringing Formulations | Niche Molecules | Difficult Molecules
With Generic Partners, a strong start heralds a strong finish:
“For topnotch results, we provide R&D leadership and collaborate with the best laboratories in their respective fields.”
What we do
We confidently handle niche molecules and difficult molecules in ways many others cannot. We produce commercially feasible, stable, non-infringing bio-equivalents of the most popular formulations in demand.
“Our patent strategies are thorough and complete; we deal with patent issues from inception all the way through to product release and after.”
What we do
We develop non-infringing strategies for ready-to-market pharmaceutical products.
CHALLENGE - Client came to us because they had not been able to produce a stable form of a generic formulation that features both immediate release and controlled release characteristics in a single formulation.
SOLUTION - Generic Partners utilised our strong rapport with a specific laboratory with the unique and sought-after capabilities required to develop a stable formulation for the proposed shelf life.
OUTCOME - Product has progressed smoothly from R&D to regulatory approval and Generic Partners has lined up a trustworthy and cost-effective manufacturer for immediate commercial production as soon as regulatory approval is obtained.
CHALLENGE - In the United States—the most demanding generic pharmaceutical marketplace in the world—the hardest regulatory challenge is to obtain First to File Paragraph IV approval. This provides the company with a billion dollar opportunity to exploit exclusive marketing rights in the US for 180 days.
SOLUTION - Generic Partners has systematically honed its R&D, IP, manufacturing and marketing capabilities in several other markets worldwide anticipating expansion into the US.
OUTCOME - Our company is on track to enter the US market in 2015 and any partners who collaborate with us shall find our business partnership highly rewarding.
CHALLENGE - Our client is licenced to market a certain dossier of products in South Africa and required expert advice to obtain regulatory approval to enter the lucrative Australian market.
SOLUTION - Generic Partners’ global R&D and regulatory teams worked with top intellectual property advisory consultants in Australia to propose a strong market entry strategy.
OUTCOME - Due to the depth of expertise and experience provided by our multidisciplinary panel of patent, R&D, regulatory and manufacturing resources, we succeeded in gaining regulatory approval in record time.
CHALLENGE - Our client is sued by a company for allegedly infringing on their patent for a pharmaceutical product.
SOLUTION - Our team draws upon our in-depth knowledge and experience in intellectual property, legal, R&D and regulatory arenas to come up with a sound defence.
OUTCOME - The barrister argues a strong case in court and saves our client’s reputation and substantial investment in product development.